PACSIN proteins in vivo: Roles in development and physiology

V Dumont, S Lehtonen - Acta Physiologica, 2022 - Wiley Online Library
Protein kinase C and casein kinase substrate in neurons (PACSINs), or syndapins (synaptic
dynamin‐associated proteins), are a family of proteins involved in the regulation of cell …

[HTML][HTML] Revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring

SZ Lim, EW Chua - Frontiers in pharmacology, 2018 - frontiersin.org
Azathioprine and 6-mercaptopurine, often referred to as thiopurine compounds, are
commonly used in the management of inflammatory bowel disease. However, patients …

NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD

Y Kakuta, T Naito, M Onodera, M Kuroha… - The …, 2016 - nature.com
The efficacy of thiopurines, including azathioprine (AZA) and 6-mercaptopurine (6MP), has
been demonstrated for the treatment of inflammatory bowel disease (IBD). The most …

The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment

S Rudin, M Marable, RS Huang - Genomics, Proteomics and …, 2017 - academic.oup.com
Pediatric acute lymphoblastic leukemia (ALL) affects a substantial number of children every
year and requires a long and rigorous course of chemotherapy treatments in three stages …

[HTML][HTML] Pharmacogenomic and pharmacotranscriptomic profiling of childhood acute lymphoblastic leukemia: paving the way to personalized treatment

S Pavlovic, N Kotur, B Stankovic, B Zukic, V Gasic… - Genes, 2019 - mdpi.com
Personalized medicine is focused on research disciplines which contribute to the
individualization of therapy, like pharmacogenomics and pharmacotranscriptomics. Acute …

Pharmacogenetics of childhood acute lymphoblastic leukemia

E Lopez-Lopez, A Gutierrez-Camino… - …, 2014 - Taylor & Francis
Acute lymphoblastic leukemia (ALL) is the major pediatric cancer in developed countries.
Although treatment outcome has improved owing to advances in chemotherapy, there is still …

Genomewide approach validates thiopurine methyltransferase activity is a monogenic pharmacogenomic trait

C Liu, W Yang, D Pei, C Cheng, C Smith… - Clinical …, 2017 - Wiley Online Library
We performed a genomewide association study (GWAS) of primary erythrocyte thiopurine S‐
methyltransferase (TPMT) activity in children with leukemia (n= 1,026). Adjusting for age and …

[HTML][HTML] Pharmacogenomics in pediatric oncology: Review of gene—Drug associations for clinical use

V Mlakar, P Huezo-Diaz Curtis… - International journal of …, 2016 - mdpi.com
During the 3rd congress of the European Society of Pharmacogenomics and Personalised
Therapy (ESPT) in Budapest in 2015, a preliminary meeting was held aimed at establishing …

Update on thiopurine pharmacogenetics in inflammatory bowel disease

RL Roberts, ML Barclay - Pharmacogenomics, 2015 - Taylor & Francis
Azathioprine and 6-mercaptopurine remain pivotal therapies for the maintenance of disease
remission in patients with Crohn's disease and ulcerative colitis. While thiopurine S …

Pharmacogenetics of treatments for inflammatory bowel disease

M Lucafò, R Franca, D Selvestrel, D Curci… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Inflammatory bowel disease is a chronic inflammation of the gut whose
pathogenesis is still unclear. Although no curative therapy is currently available, a number of …